New Multi-Partner Trust Fund launched to combat Antimicrobial Resistance globally

Milestones :: Perspectives :: Research

 

New Multi-Partner Trust Fund launched to combat Antimicrobial Resistance globally
In a major boost  to combat one of the gravest risks to global human health security,   a dedicated funding vehicle allowing national, regional and global partners to devote resources to accelerate global action against Antimicrobial Resistance (AMR) was unveiled here today at a Ministerial Conference.

Noordwijk, The Netherlands, 19 June 2019 – The Tripartite – a joint effort by the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO), launched the AMR Multi-Partner Trust Fund, which is being supported by an initial contribution of $5 million from the Government of the Netherlands.
The AMR Trust Fund has a five-year scope, through 2024, and aims to scale up efforts to support countries to counter the immediate threat of AMR, arguably the most complex threat to global health.

Antimicrobial resistance refers to the natural ability of bacteria and other microbes to develop resistance to the medicines we use to treat them, and the process is accelerated by inappropriate or excessive use of pharmaceutical products designed to kill unwanted pathogens in humans, animals and crops. In particular, the overuse and misuse of antibiotics in human and animal health is fueling resistance.

The rise of AMR, poses a threat described as a “silent tsunami”. Drug-resistant microorganisms now account for an estimated 700,000 deaths a year, a figure that could increase to 10 million deaths each year if no action is taken.

 

…Funding appeal
The immediate funding appeal is for $70 million, to be used to support countries and the implementation of the Tripartite’s AMR Workplan 2019-2020, particularly in providing technical support to countries designing National Action Plans on AMR and to scale up local action.

Prominent among the AMR Trust Fund’s ultimate desired outcomes is a world where infectious diseases can continue to be treated with effective and safe antimicrobials and one in which resistance is monitored and controlled at a slower pace. The pathway to that success entails activities ranging from awareness raising and the drafting of national action plans to surveillance of AMR trends and better ensuring responsible antimicrobial sales and use patterns.

Inaction, due to policy or implementation inadequacies, threatens to make common infections more difficult to treat and lifesaving medical procedures and treatments riskier to perform.

Inaction could also raise food insecurity and rural poverty, when animal illnesses can no longer be effectively treated using veterinary medicines.

The AMR Trust Fund provides a joint mechanism for clear attribution and transparency of all sources of finance, while its activities will be based on the application of best practices, scaling up activities that have worked and innovative approaches to ensure that today’s cures are available for future generations.

Note:
The UN Multi-Partner Trust Fund Office, the UN center of expertise in pooled funding mechanisms, will act as trustee of the Fund. The UN MPTF Office, acting as an independent trustee, will provide real-time information on contributions and use of resources of donor contributions through the MPTF Office Gateway (mptf.undp.org).